scholarly journals Androgen-Deprivation Therapy and Cardiovascular Disease Risk – The Role of Exercise in Prostate Cancer Treatment

2016 ◽  
Vol 6 ◽  
Author(s):  
Bradley Wall
Keyword(s):  
Prostate Cancer ◽  
Cardiovascular Disease ◽  
Cancer Treatment ◽  
Androgen Deprivation Therapy ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Androgen Deprivation ◽  
Prostate Cancer Treatment

scholarly journals The Use of Dietary Supplements to Alleviate Androgen Deprivation Therapy Side Effects during Prostate Cancer Treatment

Nutrients ◽  
2014 ◽  
Vol 6 (10) ◽  
pp. 4491-4519 ◽  
Author(s):  
Andrea Dueregger ◽  
Isabel Heidegger ◽  
Philipp Ofer ◽  
Bernhard Perktold ◽  
Reinhold Ramoner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Side Effects ◽  
Cancer Treatment ◽  
Dietary Supplements ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Prostate Cancer Treatment

The Effect of Androgen Deprivation Therapy Before Salvage Whole-gland Cryoablation After Primary Radiation Failure in Prostate Cancer Treatment

Urology ◽  
2015 ◽  
Vol 85 (5) ◽  
pp. 1137-1142 ◽  
Author(s):  
Roger Li ◽  
Herbert C. Ruckle ◽  
Amy E. Schlaifer ◽  
Ahmed El-Shafei ◽  
Changhong Yu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Androgen Deprivation Therapy ◽  
Androgen Deprivation ◽  
Primary Radiation ◽  
Prostate Cancer Treatment

scholarly journals Is Androgen Deprivation Therapy for Prostate Cancer Associated with Cardiovascular disease ? A Meta-Analysis and systematic review.

2019 ◽  
Author(s):  
Zhen Liang ◽  
Longlong Chen ◽  
Yawei Xu ◽  
Yongjiao Yang ◽  
Rui Hu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Cardiovascular Disease ◽  
Androgen Deprivation Therapy ◽  
Disease Risk ◽  
Meta Analysis ◽  
Androgen Deprivation ◽  
Increased Risk ◽  
Significant Difference ◽  
The Relationship

Abstract Background: Whether androgen deprivation therapy (ADT) is associated with an increased risk of developing cardiovascular related disease is poorly defined. The aim of the present meta‐analysis is to explore the relationship between ADT and the risk of cardiovascular disease (CVD). Method: For this systematic review and meta-analysis, we searched databases until April 2019 for randomized controlled trial (RCT) or observational studies that reported data on ADT administration and cardiovascular disease (CVD) incidence. The relationship was evaluated through estimate relative risk ratio (RR) and 95% confidence intervals (CIs) Result: A statistically significant difference was detected for acute myocardial infarction (AMI) (RR = 1.13; 95% CI, 1.10–1.15; P< 0.05) including a total of 142,186 cases and 174,404 controls. Significant difference between coronary heart disease (CHD) and ADT was also observed, with summary (RR=1.11; 95% confidence interval CI: 1.10-1.13), from 157,339 ADT users and 349,636 non-ADT users of 7 eligible studies. Conclusions: Pooled result demonstrated that ADT could significantly increase the risk of CHD, AMI and sudden cardiac death (SCD). Various ADT modalities have different impact on cardiovascular disease risk in different level. Our meta-analysis also suggests that the application of ADT in prostate cancer patients for over 5 years resulted in a significant increase in cardiovascular morbidity. Moreover, subgroup analyses for different types of ADT indicated that compared with the individual administration of ADT, GnRH plus AA (oral anti-androgens) is more likely significantly lead to AMI.

Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation

Urology ◽  
2016 ◽  
Vol 97 ◽  
pp. 145-152 ◽  
Author(s):  
Christopher J.D. Wallis ◽  
Alyson L. Mahar ◽  
Raj Satkunasivam ◽  
Sender Herschorn ◽  
Ronald T. Kodama ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Androgen Deprivation ◽  
Localized Prostate Cancer ◽  
Prostate Cancer Treatment ◽  
Skeletal Related Events
Sign in / Sign up

Export Citation Format

Share Document